Diary Prequel Package — page 411
of 465 pages
← p.410 p.412 → · this page in the original PDF · package
7renzy calming
onference with
from models or else it will come back to bite him. I urged him to totally resist such
predictions. He was very grateful for my advice.
Nov. 4, 2014 - GOP takes control of the Senate in today's elections. Frenzy calming
down. Little press interest - like shutting off the faucet.
Nov. 5, 2014 - Preparing for Hearings of the Senate Full Appropriations Committee
(Mikulski). Tom Frieden and I will testify together with Sylvia Burwell. POTUS
publicly requests $6.18 Billion in "emergency" funds for Ebola. We will dwefend this at
Hearing on Nov. 12.
Nov. 6, 2014 - Still calm. No Ebola Press. Did Hearing prep by teleconference with
Sylvia.
Nov. 7-11, 2014 - Still calm. Mostly preparing for Senate Appropriations Hearing on
Nov. 12. POTUS asking for $6.18 Billion in emergency funding for Ebola (Domestic
and International). NIH portion is $238 million. Went to EEOB on Nov. 10 to rehearse
for Hearing with Ron Klain.
Nov. 11 - very good meeting in Building 10, 4th Floor Medical Board Room with clinical
investigators who took care of Ebola patients at Emory, Nebraska, NIH. Also, DoD and
HHS present with presentation of individual clinical data from the USA patients. It
became clear to me that it is impossible to determine if any of the experimental drugs
given to the patients (ZMapp, Brincidofovir, favipiravir, convalescent sera, TKM-Ebola)
helped or did harm (likely did some harm. Decision was to develop a clinical protocol
for future USA patients and also to be used as prototype for Africa. Protocol should be
RCt with standard medical care (fluid and electrolyte replacement) as the control arm.
The data also suggested to me that if you keep patients alive with medical care, that the
body's immune system will almost always clear the virus (likely without experimental
drugs).
Nov. 12, 2014 - Successful Hearing today before the Full Senate Appropriations
Committee chaired by Barbara Mikulski with Richard Shelby as Ranking Minority.
Sylvia Burwell, Jeh Johnson (DHS), Michael Lumpkin (DoD), Heather Higginbottom
(DoS) testified and then accompanying witnesses went to the Table. Tom Frieden and I
were the "accompanying" witnesses for Sylvia. All went well. About 18-20 Senators
appeared. Tom Harkin made a statement that this was his last official Hearing and he
wanted to specifically call me out as a great public servant with whom he has worked on
this committee for 30 years. This elicited a round of applause from the audience.
Patrick Leahy also remarked that he has been working with me "forever". All-in-all, a
very good Hearing.
Nov. 13, 2014 - Difficult situation arising regarding the conduct of the Phase 2/3 trials of
Ebola vaccine in Liberia/Sierra Leone. The companies (first GSK; now also J & J, who
do not even have a candidate ready) are balking at going ahead with the trials unless they
get "global indemnification". This is unprecedented to demand for a Phase 2/3 trial
This is our OCR of the page, with running headers and footers removed. The
Committee's PDF
is authoritative; quote from it. Machine-readable, including the uncleaned
text: /api/page/diary_prequel/411
Records on this page
| Record | Date | Type | Pages |
|---|---|---|---|
| Nov. 3, 2014 - Ron Klain visited NIH today (He had visited CDC last week). He | 2014-11-03 | diary entry | 410–411 |
| Nov. 4, 2014 - GOP takes control of the Senate in today's elections. Frenzy calming | 2014-11-04 | diary entry | 411 |
| Nov. 5, 2014 - Preparing for Hearings of the Senate Full Appropriations Committee | 2014-11-05 | diary entry | 411 |
| Nov. 6, 2014 - Still calm. No Ebola Press. Did Hearing prep by teleconference with | 2014-11-06 | diary entry | 411 |
| Nov. 7-11, 2014 - Still calm. Mostly preparing for Senate Appropriations Hearing on | 2014-11-07 | diary entry | 411 |
| Nov. 12, 2014 - Successful Hearing today before the Full Senate Appropriations | 2014-11-12 | diary entry | 411 |
| Nov. 13, 2014 - Difficult situation arising regarding the conduct of the Phase 2/3 trials of | 2014-11-13 | diary entry | 411–412 |